Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -334.41% is 52% below its 5-year average of -219.48%, around the middle of its 5-year range (-554.78%–-18.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 33.64% below its 12-month average of -250.24%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -334.41%.
RETURN ON EQUITY (ROE)
-334.41%
RETURN ON EQUITY (ROE) AVG TTM
-250.24%
RETURN ON EQUITY (ROE) AVG 3Y
-267.92%
RETURN ON EQUITY (ROE) AVG 5Y
-219.48%
RETURN ON EQUITY (ROE) AVG 10Y
-150.94%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-33.64%
CURRENT VS 3Y AVG
-24.82%
CURRENT VS 5Y AVG
-52.36%
CURRENT VS 10Y AVG
-121.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.09%
median of 641 covered companies
CURRENT VS SECTOR MEDIAN
-734.15%
vs the sector median at left
Decoy Therapeutics Inc.
Market Cap
$845829.00
Return on Equity (ROE)
-334.41%
TTM Avg
-250.24%
3Y Avg
-267.92%
5Y Avg
-219.48%
Market Cap
$859931.00
Return on Equity (ROE)
-73.66%
TTM Avg
-87.93%
3Y Avg
-127.18%
5Y Avg
-86.65%
Market Cap
$869274.00
Return on Equity (ROE)
-21.18%
TTM Avg
-23.90%
3Y Avg
-48.17%
5Y Avg
-962.79%
Market Cap
$869976.00
Return on Equity (ROE)
N/A
TTM Avg
-255.88%
3Y Avg
-273.58%
5Y Avg
-200.54%
Market Cap
$816286.00
Return on Equity (ROE)
-77.23%
TTM Avg
-124.66%
3Y Avg
-168.43%
5Y Avg
-110.88%
Market Cap
$809925.00
Return on Equity (ROE)
N/A
TTM Avg
15.66%
3Y Avg
-28.27%
5Y Avg
-26.31%
Market Cap
$669300.00
Return on Equity (ROE)
6.58%
TTM Avg
129.48%
3Y Avg
106.12%
5Y Avg
-3462.32%
Market Cap
$1.04M
Return on Equity (ROE)
-93.97%
TTM Avg
234.49%
3Y Avg
123.23%
5Y Avg
1171.22%
Market Cap
$1.06M
Return on Equity (ROE)
-57.87%
TTM Avg
-222.45%
3Y Avg
-164.72%
5Y Avg
-135.78%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $845829.00 | -334.41% | -250.24% | -267.92% | -219.48% |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | -73.66% | -87.93% | -127.18% | -86.65% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $869274.00 | -21.18% | -23.90% | -48.17% | -962.79% |
| GlucoTrack, Inc. (GCTK)vs › | $869976.00 | N/A | -255.88% | -273.58% | -200.54% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $816286.00 | -77.23% | -124.66% | -168.43% | -110.88% |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A | 15.66% | -28.27% | -26.31% |
| CDT Equity Inc. (CDT)vs › | $669300.00 | 6.58% | 129.48% | 106.12% | -3462.32% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | -93.97% | 234.49% | 123.23% | 1171.22% |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | -57.87% | -222.45% | -164.72% | -135.78% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | -11.85% | -6.20% | 47.36% | 47.36% |
ROE
-334.4%
ROA
-160.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -334.41% |
| 2026-03-31 | -336.14% |
| 2025-12-31 | -212.58% |
| 2025-09-30 | -117.81% |
| 2024-12-31 | -368.84% |
| 2024-09-30 | -170.75% |
| 2024-06-30 | -272.14% |
| 2024-03-31 | -244.34% |
| 2023-12-31 | -237.22% |
| 2023-09-30 | -296.40% |
| 2023-06-30 | -356.54% |
| 2023-03-31 | -554.78% |
| 2022-12-31 | -304.37% |
| 2022-09-30 | -176.63% |
| 2022-06-30 | -60.45% |
| 2022-03-31 | -50.95% |
| 2021-12-31 | -32.97% |
| 2021-09-30 | -24.46% |
| 2021-06-30 | -18.34% |
| 2021-03-31 | -14.60% |
| 2020-12-31 | -33.18% |
| 2020-09-30 | -36.24% |
| 2020-06-30 | -49.71% |
| 2020-03-31 | -41.65% |
| 2019-12-31 | -72.25% |
| 2019-09-30 | -79.80% |
| 2019-06-30 | -127.54% |
| 2019-03-31 | -219.01% |
| 2018-12-31 | -236.16% |
| 2018-09-30 | -252.86% |
| 2018-06-30 | -258.28% |
| 2018-03-31 | -157.11% |
| 2017-12-31 | -118.30% |
| 2017-09-30 | -94.81% |
| 2017-06-30 | -80.02% |
| 2017-03-31 | -73.08% |
| 2016-12-31 | -66.58% |
| 2016-09-30 | -59.80% |
| 2016-06-30 | -49.46% |
| 2016-03-31 | -38.87% |
| 2015-12-31 | -31.61% |
| 2015-09-30 | -21.68% |
| 2015-06-30 | -14.41% |
| 2015-03-31 | -9.26% |
